Illness	Number of cases
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	144
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	85
Hyperplasia of prostate (N40)	76
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	71
Malignant neoplasm of prostate (C61)	47
Calculus of kidney and ureter - Calculus of kidney (N20.0)	43
Unspecified haematuria (R31)	32
Cystitis (N30.0)	28
Calculus of kidney and ureter - Calculus of ureter (N20.1)	24
Complications of genitourinary prosthetic devices implants and grafts (T83.0)	17

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	304
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	167
Examination of the urethra and the urinary bladder by endoscopy (1-661)	135
(1-999.40)	116
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0)	112
Insertion, exchange or removal of a ureteral stent (8-137.00)	102
Insertion, exchange or removal of a ureteral stent (8-137.10)	96
(9-984.8)	64
Surgical dilatation of the opening of a ureter by incision, removal of tissue or other technique (5-561.7)	63
(9-984.7)	56

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
47	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
31	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
28	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility